PalbociclibAcquired drug resistance and off-label use

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 1999卷 / 1期
关键词：
D O I：
10.1007/s40278-024-54616-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 307
相关论文
共 50 条
  • [1] Off-label drug use in children
    Jain S.S.
    Bavdekar S.B.
    Gogtay N.J.
    Sadawarte P.A.
    The Indian Journal of Pediatrics, 2008, 75 (11) : 1133 - 1136
  • [2] Off-Label Drug Use and Promotion
    Gianutsos, Gerald
    US PHARMACIST, 2014, 39 (10) : 55 - 64
  • [3] Appropriate off-label drug use
    Lee, Sang Moo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2018, 61 (03): : 140 - 146
  • [4] Off-Label Drug Use in Children
    Jain, Surabhi S.
    Bavdekar, S. B.
    Gogtay, Nithya J.
    Sadawarte, Pranjali A.
    INDIAN JOURNAL OF PEDIATRICS, 2008, 75 (11): : 1133 - 1136
  • [5] Off-label drug use in hospitals
    Danes, Imma
    Alerany, Carmen
    Ferrer, Anna
    Vallano, Antoni
    MEDICINA CLINICA, 2014, 143 (07): : 327 - 328
  • [6] AntineoplasticsTreatment failure, drug resistance and off-label use: case report
    Reactions Weekly, 2022, 1931 (1) : 85 - 85
  • [7] ErtapenemAcquired drug resistance following off-label use: case report
    Reactions Weekly, 2022, 1909 (1) : 245 - 245
  • [8] Cetuximab/encorafenibDevelopment of drug resistance and off-label use: case report
    Reactions Weekly, 2022, 1894 (1) : 103 - 103
  • [9] Alectinib/crizotinibAcquired drug resistance and off-label use: case report
    Reactions Weekly, 2021, 1856 (1) : 23 - 23
  • [10] Off-label Drug Use and Adverse Drug Events Turning up the Heat on Off-label Prescribing
    Good, Chester B.
    Gellad, Walid F.
    JAMA INTERNAL MEDICINE, 2016, 176 (01) : 63 - 64
12345